P. Moller et al., The BRCA1 syndrome and other inherited breast or breast-ovarian cancers ina Norwegian prospective series, EUR J CANC, 37(8), 2001, pp. 1027-1032
Inherited breast cancer is a heterogenous group of diseases. We examined th
is heterogeneity in a prospective series of inherited breast and ovarian ca
ncers. previously demonstrated to include 84% of inherited cancers. Ninety-
two tumours (65 breast and 97 ovarian) in 82 patients from 70 kindreds were
prospectively diagnosed. Fifteen of the breast cancers were in situ, 50 we
re infiltrating. 40 (49%) of the 82 women carried a BRCA1 mutation. whereas
no mutation in BRCA2 was found. Approximately, two-thirds of the BRCA1 mut
ation carriers had one of the four most frequent Norwegian founder mutation
s. Ninety-five per cent of the epithelial ovarian cancers occurred in BRCA1
mutation carrying women versus 38% of infiltrating breast cancers and 7% o
f carcinoma in situ of the breast. The BRCA1 syndrome was phenotypically di
stinct with invasive. high grade, oestrogen receptor-negative breast cancer
s and epithelial ovarian cancers. Non-BRCA1/2 inherited breast cancers incl
uded carcinoma in situ and lobular carcinoma and were frequently bilateral.
Non-BRCA1/2 inherited breast cancer is not associated with epithelial ovar
ian cancer and in breast cancers has distinct biological characteristics, i
ndicating that the different subgroups of inherited breast cancer may need
different healthcare services, (C) 2001 Elsevier Science Ltd. All rights re
served.